{"id":7681,"date":"2017-06-26T08:25:09","date_gmt":"2017-06-26T07:25:09","guid":{"rendered":"https:\/\/www.curiumpharma.com\/2017\/06\/26\/panel-of-mo-99-producers-say-supplies-are-secure-outline-investments-made-to-bolster-future-of-supply-panel-convenes-at-nuclear-medicine-meeting-in-denver\/"},"modified":"2018-11-11T00:25:36","modified_gmt":"2018-11-11T00:25:36","slug":"panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in","status":"publish","type":"post","link":"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/","title":{"rendered":"Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver."},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7681","post","type-post","status-publish","format-standard","hentry","category-uncategorised"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver. - Curium Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver. - Curium Pharma\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/\" \/>\n<meta property=\"og:site_name\" content=\"Curium Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2017-06-26T07:25:09+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-11-11T00:25:36+00:00\" \/>\n<meta name=\"author\" content=\"curiumadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"curiumadmin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2017\\\/06\\\/26\\\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2017\\\/06\\\/26\\\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\\\/\"},\"author\":{\"name\":\"curiumadmin\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#\\\/schema\\\/person\\\/78a85cd6e0b6e575590a841bb7d14c32\"},\"headline\":\"Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver.\",\"datePublished\":\"2017-06-26T07:25:09+00:00\",\"dateModified\":\"2018-11-11T00:25:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2017\\\/06\\\/26\\\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\\\/\"},\"wordCount\":29,\"articleSection\":[\"Uncategorised\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2017\\\/06\\\/26\\\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\\\/\",\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2017\\\/06\\\/26\\\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\\\/\",\"name\":\"Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver. - Curium Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#website\"},\"datePublished\":\"2017-06-26T07:25:09+00:00\",\"dateModified\":\"2018-11-11T00:25:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#\\\/schema\\\/person\\\/78a85cd6e0b6e575590a841bb7d14c32\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2017\\\/06\\\/26\\\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2017\\\/06\\\/26\\\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/2017\\\/06\\\/26\\\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/\",\"name\":\"Curium Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.curiumpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#\\\/schema\\\/person\\\/78a85cd6e0b6e575590a841bb7d14c32\",\"name\":\"curiumadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4d16732481a0857eb566b89b1da910bdc0b4f4ed1e72645fe02e722393ded9f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4d16732481a0857eb566b89b1da910bdc0b4f4ed1e72645fe02e722393ded9f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f4d16732481a0857eb566b89b1da910bdc0b4f4ed1e72645fe02e722393ded9f?s=96&d=mm&r=g\",\"caption\":\"curiumadmin\"},\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/nl\\\/author\\\/curiumadmin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver. - Curium Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/","og_locale":"nl_NL","og_type":"article","og_title":"Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver. - Curium Pharma","og_url":"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/","og_site_name":"Curium Pharma","article_published_time":"2017-06-26T07:25:09+00:00","article_modified_time":"2018-11-11T00:25:36+00:00","author":"curiumadmin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"curiumadmin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/#article","isPartOf":{"@id":"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/"},"author":{"name":"curiumadmin","@id":"https:\/\/www.curiumpharma.com\/#\/schema\/person\/78a85cd6e0b6e575590a841bb7d14c32"},"headline":"Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver.","datePublished":"2017-06-26T07:25:09+00:00","dateModified":"2018-11-11T00:25:36+00:00","mainEntityOfPage":{"@id":"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/"},"wordCount":29,"articleSection":["Uncategorised"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/","url":"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/","name":"Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver. - Curium Pharma","isPartOf":{"@id":"https:\/\/www.curiumpharma.com\/#website"},"datePublished":"2017-06-26T07:25:09+00:00","dateModified":"2018-11-11T00:25:36+00:00","author":{"@id":"https:\/\/www.curiumpharma.com\/#\/schema\/person\/78a85cd6e0b6e575590a841bb7d14c32"},"breadcrumb":{"@id":"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.curiumpharma.com\/nl\/2017\/06\/26\/panel-van-mo-99-producenten-verklaart-dat-de-toelevering-verzekerd-is-en-schetst-investeringsplannen-voor-toelevering-in-de-toekomst-het-panel-kwam-bijeen-tijdens-een-nuclear-medicine-bijeenkomst-in\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.curiumpharma.com\/nl\/"},{"@type":"ListItem","position":2,"name":"Panel van Mo-99 producenten verklaart dat de toelevering verzekerd is en schetst investeringsplannen voor toelevering in de toekomst. Het panel kwam bijeen tijdens een nuclear medicine bijeenkomst in Denver."}]},{"@type":"WebSite","@id":"https:\/\/www.curiumpharma.com\/#website","url":"https:\/\/www.curiumpharma.com\/","name":"Curium Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.curiumpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Person","@id":"https:\/\/www.curiumpharma.com\/#\/schema\/person\/78a85cd6e0b6e575590a841bb7d14c32","name":"curiumadmin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/secure.gravatar.com\/avatar\/f4d16732481a0857eb566b89b1da910bdc0b4f4ed1e72645fe02e722393ded9f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f4d16732481a0857eb566b89b1da910bdc0b4f4ed1e72645fe02e722393ded9f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f4d16732481a0857eb566b89b1da910bdc0b4f4ed1e72645fe02e722393ded9f?s=96&d=mm&r=g","caption":"curiumadmin"},"url":"https:\/\/www.curiumpharma.com\/nl\/author\/curiumadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/posts\/7681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/comments?post=7681"}],"version-history":[{"count":0,"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/posts\/7681\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/media?parent=7681"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/categories?post=7681"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curiumpharma.com\/nl\/wp-json\/wp\/v2\/tags?post=7681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}